Skip to content

Clinical trials

Phase 2 Nasopharyngeal Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Carcinoma Phase: Phase 2 Clear all

236 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20061
20074
20085
20095
20106
20116
20125
20133
20147
20158
201611
201710
201814
201915
202021
202119
202224
202311
202422
202518
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status92
Completed51
Recruiting38
Not yet recruiting24
Active, not recruiting16
Terminated8
Withdrawn4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University70
Fudan University15
Zhejiang Cancer Hospital11
Fujian Cancer Hospital9
National Cancer Institute (NCI)6
Jiangxi Provincial Cancer Hospital4
National University Hospital, Singapore4
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4
The University of Hong Kong4
Affiliated Cancer Hospital & Institute of Guangzhou Medical University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Carcinoma236
Nasopharyngeal Neoplasms20
Recurrence15
Neoplasm Metastasis10
Epstein-Barr Virus Infections6
Stomatitis6
Squamous Cell Carcinoma of Head and Neck5
Carcinoma4
Mouth Neoplasms4
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 76 to 100 of 236. Each trial links to its page on Pharma Observatory.

136 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.